Mass screening for prostate cancer with a test for prostate-specific antigen (PSA) has led to mass over-diagnosis and over-treatment, according to a study published in the Journal of the National Cancer Institute. Since the PSA screening test came into use in 1986, federal government data show that the number of prostate cancer cases in the United States has risen substantially.More »